Abstract

Furthermore, not only the dilated kidney tubules and ectatic Bowman spaces, but also the dark needle-like urate crystals, focal tubulointerstitial fibrosis and glycometabolic disorder were more evident in the kidneys of mice treated with Ade-100 + OXO-500, further illustrating the more severe kidney injury [Figure 1G and 1H] in this group of mice. Immunohistochemistry of kidneys from mice administrated with adenine and OXO showed massive accumulation of URAT1 and GLUT9 in injured tubules, meaning the increase of uric acid re-absorption in the proximal renal tubules. [...]we attempted to create mouse model of hyperuricemia by injecting mouse with adenine and OXO.

Details

Title
A novel mouse model of hyperuricemia and gouty nephropathy
Author
Guan, Jin 1 ; Xiao-Qi, Huang 2 ; Jia-Le, Dong 1 ; Hui-Min, Lu 3 ; Yue-Wei, Lin 4 ; Liu, Mei 2 ; Zhi-Biao, Yi 5 ; Li-Min, Wu 3 ; Yong-Ming, Huang 4 ; Tian, Lan 1 

 Department of Pharmacology, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China 
 Guangzhou University of Chinese Medicine, Math Engineering Academic Chinese Medicine, Guangdong Province of Key Lab New Drug Dev & Res Chinese, Guangzhou, Guangdong 510006, China; Guangzhou University of Chinese Medicine, Dongguan Math Engineering Academic Chinese Medicine, Dongguan, Guangdong 523808, China 
 Foshan Santanyi Biotech Co., Ltd, Foshan, Guangdong 528031, China 
 Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China 
 Guangzhou University of Chinese Medicine, Dongguan Math Engineering Academic Chinese Medicine, Dongguan, Guangdong 523808, China 
Pages
2012-2014
Section
Correspondence
Publication year
2020
Publication date
Aug 2020
Publisher
Lippincott Williams & Wilkins Ovid Technologies
ISSN
03666999
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2480935114
Copyright
Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.